First humans take experimental pill in groundwork study
NCT ID NCT07412288
Summary
This is the first study to give a new oral drug called KT-579 to people. Its main goal is to check if the drug is safe and how the body processes it in healthy adult volunteers. Researchers will test different single and repeated doses, comparing them to a placebo, to gather initial safety data.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Celerion
RECRUITINGLincoln, Nebraska, 68502, United States
Conditions
Explore the condition pages connected to this study.